InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by WEST MICHAEL D, Chairman & CEO. Director active across 1 companies, notably AgeX Therapeutics, Inc.. Cumulatively, 8 reports have been recorded. The latest transaction was filed on 11 June 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
03,125 shares0
Common Stock, $0.0001 par value
SEC:0001209191-22-036809:0·
03,125 shares0
Common Stock, $0.0001 par value
SEC:0001209191-22-019000:0·
03,125 shares0
Common Stock, $0.0001 par value
SEC:0001209191-21-069617·
03,125 shares0
Common Stock, $0.0001 par value
SEC:0001209191-21-069617:0·
03,125 shares0
Common Stock, $0.0001 par value
SEC:0001209191-21-057189·
03,125 shares0
Common Stock, $0.0001 par value
SEC:0001209191-21-057189:0·
03,125 shares0
Common Stock, $0.0001 par value
SEC:0001209191-21-040796·
03,125 shares0
Common Stock, $0.0001 par value
SEC:0001209191-21-040796:0·
8 of 8 declarations
About WEST MICHAEL D
WEST MICHAEL D is the Chief Executive Officer of AgeX Therapeutics, Inc. He leads the operations and strategy of the company, ensuring its success and growth. His role is essential for setting clear objectives and guiding the team towards achieving those goals. Michael is committed to promoting innovation and excellence in the biotechnology field.
